header

Publikationen Professor Junghanß

Liu W, Beck J, Schmidt LC, Roolf C, Pews-Davtyan A, Rütgen BC, Hammer S, Willenbrock S, Sekora A,         Rolfs A, Beller M, Brenig B, Nolte I, Junghanss C, Schütz E, Escobar HM
Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.
Oncotarget. 2016 May 12. doi: 10.18632/oncotarget.9297. [Epub ahead of print]

 

 

 

Publikationen 2014

  • Moeller M, Hirose M, Mueller S, Roolf C, Baltrusch S, Ibrahim S, Junghanss C, Wolkenhauer O, Jaster R, Köhling R, Kunz M, Tiedge M, Schofield PN, Fuellen G.
    Inbred mouse strains reveal biomarkers that are pro-longevity, antilongevity or role switching.
    Aging Cell. 2014 May 23. [Epub ahead of print] PMID:24862908
  • Kretzschmar C, Roolf C, Langhammer TS, Sekora A, Pews-Davtyan A, Beller M, Frech MJ, Eisenlöffel C, Rolfs A, Junghanss C.
    The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells.
    BMC Cancer. 2014;14:71. PMID:24502201
  1. Wolkenhauer O., Auffray C., Baltrusch S., Blüthgen N., Byrne H., Cascante M., Ciliberto A., Dale T., Drasdo D., Fell D., Ferrell JE Jr., Gallahan D., Gatenby R., Günther U., Harms BD., Herzel H., Junghanss C., Kunz M., van Leeuwen I., Lenomand P., Levi F., Linnebacher M., Lowengrub J., Maini PK, Malik A., Rateitschak K., Sansom O. Schäfer R., Schürrle K., Sers C., Schnell S., Shibata D., Tyson J., Vera J., White M., Zhivotovsky B., Jaster R. (2010) Systems biologists seek fuller integration of sysstems biology approaches in new cancer research programms. Cancer Res.  2010 Jan 1;70(1):12-3. 

  2. Leithäuser M., Kahl C., Aepinus C., Prall F., Maruschke M., Riemer H., Wolff D., Jost K., Hilgendorf I., Freund M., Junghanss C. (2010) Invasive zygomycosis in patients with graft-versus-host disease after allogenetic stem cell transplantation. Transpl. Infect Dis. [Ahead of print]

  3. Schult C,Dahlhaus M, Ruck S, Sawitzky M, Amoroso F, Lange S, Etro D, Glass A,Fuellen G,Boldt S, Wolkenhauer O, Neri LM, Freund M, Junghanss C. The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. BMC Cancer. 2010;10(1):560 IF: 2.74

  4. J. Fitting., D. Killian, C. Junghanss, S. Willenbrock., H. Murua Escobar, I. Nolte , S. Lange, S. Barth, M.K.Tur. Generation of recombinant antibody fragments by phage display technology targeting canine dendritic cells. (Vet Comp Oncol., accepted for publication) IF: 0.804

  5. Sterenczak KA, Joetzke AE, Willenbrock S, Eberle N, Lange S, Junghanss C, Nolte I, Bullerdiek J, Simon D, Murua Escobar H. High-mobility Group B1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE) Expression in Canine Lymphoma. Anticancer Res. 2010 (12):5043-8   IF: 1.43

  6. Hilgendorf I, Loebermann M, Borchert K, Junghanss C, Freund M, Schmitt M. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD. Bone Marrow Transplant. 2010 Dec 13. [Epub ahead of print] IF: 2.998

  7. Goekbuget N, Hartog CM, Bassan R, Derigs HG, Dombret H, Greil R, Hernandez-Rivas JM, Huguet F, Intermesoli T, Jourdan E, Junghanss C, Leimer L, Moreno MJ, Reichle A, Ribera JM, Schmid M, Serve H, Stelljes M, Stuhlmann R, Hoelzer D. Liposomal cytarabine is effective and tolerable in the treatment of CNS relapse of acute lymphoblastic leukemia (ALL) and very aggressive lymphoma. Haematologica. 2010 Oct 15. [Epub ahead of print] IF: 6.416

  8. Kahl C, Hirt C, Decker S, Gläser D, Rohde S, Jost K, Hilgendorf I, Respondek-Dryba E, Leithäuser M, Junghanss C, Freund M. Multimodal therapy for localized spinal epidural follicular lymphoma. Onkologie. 2010;33(7):381-4. IF: 1.234

  9. Hilgendorf I, Wolff D, Gromke T, Trenschel R, Elmaagacli AH, Pichlmeier U, Junghanss C, Freund M, Beelen DW, Casper J. Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome. Bone Marrow Transplant. 2010 Jun 28.[Epub ahead of print] IF: 2.998

 

          Abstracts

  1. Schult C, Fischer K, Dahlhaus M, Goetz M, Lange S, Freund M, Junghanss C. Concomitant treatment of Sorafenib with dexamethasone enhances antiproliferative effects in lymphoblastic cells. Onkologie 2010;33 (suppl 6):236
  2. Goetz M, Schult C, Dahlhaus M, Fischer K, Freund M, Junghanss C 168MiR-155 expression in acute leukemia cells treated with the multikinase inhibitor sorafenib. EJC 2010;8 (7):58
  3. Killian D, Knueppel A, Willenbrock S, Escobar HM, Heisterkamp M, Lubatschowski H, Nolte I, Sekora A, Freund M, Junghanss C. Influence of high mobility group Box 1 on allogeneic immune responses. Bone Marrow Transplantation. 2010;45:278
  4. Killian D, Knueppel A, Lange S, Dunkelmann S, Fitting J, Willenbrock S, Wefstaedt P, Escobar HM, Nolte I, Barth S, Sekora A, Freund M, Junghanss C. Migration of canine dendritic cells can be detected by radioactive-labelling and varies according to injection sites. Bone Marrow Transplantation. 2010; 45:S278
  5. Knueppel A, Killian D, Lange S, Sekora A, Freund M, Junghanss C. Recovery of regulatory T-cells following non-myeloablative DLA-identical littermate allogeneic stem cell transplantation. Bone Marrow Transplantation. 2010;45:276-277
  6. Knueppel A, Killian D, Lange S, Sekora A, Freund M, Junghanss C. Intra-bone marrow transplantation of allogeneic DLA-identical CD34+cells allows successful engraftment in DLA-identical canine litters following non-myeloablative conditioning. Bone Marrow Transplantation. 2010;45:277
  7. Knueppel A, Killian D, Lange S, Vogel H, Lindner I, Dunkelmann S, Prall F, Freund M, Knuebel G, Sekora A, Junghanss C. Intra-Bone Marrow Transplantation of CD34+ Enriched Grafts Following a Non-Myeloablative Conditioning Allows Successful Engraftment In DLA-Identical Canine Litters. Blood. 2010;116:21
  8. M. Schomaker, D. Killian; S. Willenbrock, E. D. Diebold, E. D. Mazur, W. Bintig, A. Ngezahayo, I. Nolte, H. Murua Escobar, C. Junghanss, H. Lubatschowski, A. Heisterkamp. Ultrashort laser pulse cell manipulation using nano- and micro- materials. Optics and Photonics Proceedings 2010:7762, P77623
  9. Killian D, Sekora A, Schomaker M, Willenbrock S, Knueppel A, Murua Escobar H, Heisterkamp A, Nolte I, Freund M, Junghanss C. Different approaches for the transfection of canine hematopoietic stem cells. First PhD symposium of the Berlin-Brandenburg School of Regenerative Therapies on Stem cells: Hopes, Fears and Reality”.2010;S17
  1. Kahl C, Leithäuser M, Junghanss C, Prall F, Freund M. (2009) Pancytopenia and lymph node swelling: unusual coincidence of systemic lupus erythematodes and Epstein-Barr-virus infection. Internist 50(6):734-9 [IF = 0,271]
  2. Lange S., Altmann S, Brandt B, Adam C, Riebau F. Vogel H, Weirich V, Hilgendorf I, Storb R, Freund M, Junghanss C. (2009) Investigation of immunological approaches to enhance engraftment in a 1Gy TBI canine hematopoietic stem cell transplantation model. Exp Hematol. 37(1):143-50 [IF = 3,147]
  3. Basara N, Schulze A, Wedding U, Mohren M, Gerhard A, Junghanss C, Peter N, Dölken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Haifa AA, Niederwieser D. (2009) Early related or unrelated hematopoietic stem cell transplantation results in higher overall and leukemia free survival compared to conventional chemotherapy in high risk acute myeloid leukemia (AML) patients. Leukemia 23(4):635-40 [IF = 6,924]
  4. Böhme A, Ruhnke M, Buchheidt D, Cornely O, Einsele H, Enzensberger R, Hebart H, Heinz W, Junghanss C, Karthaus M, Krüger W, Krug U, Kubin T, Penack O, Reichert D, Reuter, S, Silling G, Südhoff T, Ullmann A, Maschmeyer G. (2009) Treatment of invasive fungal infections in patients with hematooncological malignancies – Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 88(2):97-110 [IF = 2,342]
  5. Lange S, Altmann S, Vogel H, Weirich V, Freund M, Junghanss C. Graft Enrichment with host-derived mature dendritic cells does not allow long-term engraftment in dogs after conditioning with 1 Gy TBI followed by DLA-identical hematopoietic stem cell transplantation. Transplantation Proceedings (eingereicht 6/2008, in Begutachtung)
  6. Knueppel A; Lange S, Sekora A, Altmann S, Freund M, Junghanss C. Phenotyping and functional characterization of canine regulatory T cells in allogeneic immuneresponses. Veterinary Immunology and Immunopathology (eingereicht 5/2009)
  7. Ruck S, Aepinus C, Jost K, Hilgendorf  I, Donat M, Prall F, Rösler K, Leithäuser M, Kahl C, Freund M, Junghanss C. Pulmonary infection with Nocardia abscessus in an allogeneic hemtaopoietic stem cell recipient. Transplant Infectious Disease (eingereicht 5/2009)
  8. Leithauser M, Kahl C, Aepinus C, Prall F, Maruschke M, Riemer H, Wolff D, Jost K, Hilgendorf I, Freund M, Junghanss C. Invasive zygomycosis in patients with graft versus host. Transplant Infectious Disease (im Druck)
  1. Lange S, Müller SC, Altmann S, Dahlhaus S, Drewelow B, Freund M, Junghanss C (2008) Pharmacokinetics of oral mycophenolate mofetil in combination with CSA in dogs after non-myeloablative allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 41(7):667-74 [IF = 3,000]
  2. Hilgendorf I, Aepinus C, Wolff D, Leithaeuser M, Junghanss C, Casper J, Freund M. (2008) Visual deterioration after gram-negative sepsis in neutropenia. Ann Hematol.87(2):155-7. [IF = 2,342]
  3. Jost K, Leithäuser M, Große-Thie C, Bartolomaeus A, Hilgendorf I, Andree H, Casper J, Freund M, Junghanss C (2008) Perforation of the superior vena cava – a rare complication of central venous catheters. Onkologie 31(5):262-4 [IF = 1,227]
  4. Ruck S, Hilgendorf I, Müller-Hilke B, Kiefel V, Junghanss C, Freund M, Greinix H, Wolff D. (2008) Autoantibody-mediated agranulocytosis in association with chronic GVHD. Bone Marrow Transplant. 42(5):359-60 [IF = 3,000]
  5. Andree H, Hilgendorf I, Leithaeuser M, Junghanss C, Holzhueter S, Loddenkemper C, Steiner B, Freund M, Wolff D. (2008) Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD. Bone Marrow Transplant. 42(8):541-6   [IF = 3,000]
  6. Wolff D, Andree H, Hilgendorf I, Casper J, Freund M, Junghanss C. (2008) Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucial. Biol Blood Marrow Transplant. 14(8):942-3. [IF = 3,797]
  7. Altmann S, Lange S, Pommerencke J, Murua Escobar H, Bullerdiek J, Nolte I, Freund M, Junghanss C (2008) High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity. Vet Immunol. Immunopathol. 126(3-4):367-72 [IF = 1,957]
  8. Hilgendorf i, Wolff D, Junghanss C, Kahl C, Leithaeuser M, Steiner B, Casper J, Freund M. (2008) Neurogical complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation. Ann Hematol. 87(12):1009-12 [IF = 2,342]
  1. Hilgendorf I, Casper J, Sviland L, Prall F, Junghanss C, Freund M, Wolff D.(2007) Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 39(4):245-6 [IF = 3,000]
  2. Meyer B, Krisponeit D, Junghanss C, Murua Escobar H, Bullerdiek J. (2007) Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count. Leuk Lymphoma. 48(10):2008-13 [IF = 1,512]
  1. Junghanss C (2006) The kinetics of cytomegalovirus load in allogeneic hematopoietic stem cell transplant recipients. Haematologica. 91(1):5B [Editorial] [IF = 5,032]
  2. Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hanel M, Dolken G, Junghanss C, Andreesen R, Bertz H; Itraconazole Research Group of Germany. (2006) An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother; 57(2):317-25. [IF = 3,891]
  3. Hilgendorf I, Wolff D, Wilhelm S, Steiner B, Kiefel V, Hickstein H, Junghanss C, Freund M, Casper J. (2006) T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infection. Bone Marrow Transplantation,  37(10):977-8.[IF = 2,621]
  4. Wolff D, Frei E, Hofmeister N, Steiner B, Kleine HD, Junghanss C, Sievert K, Terpe H, Schrenk HH, Freund M, Hartung G. (2006) Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease. Transplantation. 82(4):527-33. [IF = 3,972]
  5. Wolff D, Wilhelm S, Hahn J, Gentilini C, Hilgendorf I, Steiner B, Kahl C, Junghanss C, Hartung G, Casper J, Uharek L, Holler E, Freund M. (2006) Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplant.38(6):445-51.[IF = 2,621]
  6. Hilgendorf I, Wilhelm S, Prall F, Junghanss C, Steiner B, Wolff D, Freund M, Casper J. (2006) Headache after haematopoietic stem cell transplantation: being aware of chronic bilateral subdural hematoma. Leuk Lymphoma. 47(10):2247-9. [IF = 1,559]
  1. D. Wolff, A. Knopp, V. Weirich, B.Steiner, C. Junghanss, J. Casper, and M. Freund. (2005) Loss of the GVL effect by loss of the Y-chromosome as putative mechanism of immune escape in ALL. Bone Marrow Transplantation,;35(1):101-2.[IF = 2,643]
  2. Hilgendorf, I., Weirich, V., Zeng, L., Koppitz, E., Wegener, R., Freund, M. and Junghanss, C.(2005) Canine hematopoietic chimerism analyses by semiquantitative fluorescence detection of variable number of tandem repeat polymorphism. Veterinary Research Communications, 29(2):103-110 [IF = 0,328]
  3. Wolff D, Roessler V, Steiner B, Wilhelm S, Weirich V, Brenmoehl J, Leithäuser M, Hofmeister N, Junghanss C, Casper J, Hartung G, Holler E and Freund M.(2005) Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplantation; 35(10):1003-10. [IF = 2,643]
  4. Junghanss C, Waak M, Knopp A, Kleine HD, Kundt G, Leithauser M, Hilgendorf I, Wolff D, Casper J and Freund M.(2005) Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. Neoplasma, 52(5):402-10.                                    [IF = 0,731]
  5. Casper J, Wilhelm S, Steiner B, Wolff D, Grobe N, Hahling D, Hartung G, Hilgendorf I, Luck A, Junghanss C, Kahl C, Baumgart J, Pichlmeier U, Freund M.(2005) Allogeneic blood stem cell transplantation of high-risk patients after conditioning with treosulfan and fludarabine. Dtsch Med Wochenschr.,130(38):2125-9.                        [IF = 0,653]
  6. Junghanss C (2005) Cytomegalovirus infections following chemotherapies of the newer generation Haematologica, 90(12):1591 [Editorial]                [IF = 4,575]

Wolff, D., Steiner, B., Stilgenbauer, S., Kahl, C., Leithäuser, M., Junghanss, C., Wilhelm, S., Kleine, HD,  Zimmermann, R, Hartung, G, Casper, J and Freund, M. (2004) Treatment with Campath-1H for relapse of chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation did not abrogate the development of chronic GVHD. European Journal of Haematology, 72(2):145-8.[IF = 1,729]

  1. Junghanss,C. Takatu,A., Little,M.T., Zaucha,J.M., Zellmer, E.,Yunosov,M., Sale,G., Georges,G.E., Torok-Storb,B., & Storb,R. (2003) Adoptive immunotherapy against kidney targets in in dog-leukocyte antigen- identical mixed hematopoietic canine chimeras. Transplantation 75 (3):268-274 [IF = 3,608]
  2. D. Buchheidt, A. Böhme, OA Cornely,G Fätkenheuer, HG Fuhr, G. Heussel, C. Junghanss, M. Karthaus, O. Kellner, WV Kern, X. Schiel, O. Sezer, T. Südhoff, H. Szelenyi. (2003) Diagnosis and treatment of documented infections in neutropenic patients. Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 82 (Suppl 2):127-132. [IF = 1,241]
  3. A. Böhme, M. Ruhnke, D. Buchheidt, M. Karthaus, H. Einsele, S. Guth, G. Heussel, CP Heussel, C. Junghanss, WV Kern, T. Kubin, G. Maschmeyer, O. Sezer, G. Silling, T. Südhoff, H. Szelenyi, AJ. Ullmann. (2003) Treatment of fungal infections in hematology and oncology. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 82 (Suppl 2):133-40. [IF = 1,241]
  4. Junghanss,C., Storb, R., Maris, M.B., Carter,R.A., Sandmaier,B.M., Maloney,D.G., McSweeney,P.A., Corey,L .&Boeckh, M.(2003) Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after nonmyeloablative allogeneic stem cell transplantation. British Journal of Haematology, 123(4):662-70  [IF = 3,267]
  1. Junghanss,C., Boeckh,M., Carter,R.A., Sandmaier,B.M., Maris, M.B., Maloney,D.G., Chauncey,T., McSweeney,P.A., Little,M.T., Corey,L. & Storb,R. (2002) Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood, 99, 1978-1985. [IF = 9,631]
  2. Nakai,K., Mineishi,S., Kami,M., Kanda,Y., Tanosaki,R., Takaue,Y., Junghanss,C., Storb,R. & Boeckh,M. (2002) Chimerism induction and delayed onset of cytomegalovirus (CMV) infection after allogeneic reduced-intensity stem cell transplantation (RIST) Blood, 100(7): 2674-2675 [Letter] [IF = 9,631]
  3. Kuhr,C., Allen,M.D., Junghanss,C., Yunusov,M., Torok-Storb,B., Little,M.T., & Storb,R. (2002) Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation, 73 (9):1487-1492. [IF = 3,265]
  4. Junghanss,C., Marr,K., Carter,R.A., Sandmaier,B.M., Maris,M.B., Maloney,D.G., Chauncey,T., McSweeney,P.A., & Storb,R. (2002) Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared to myeloablative allogeneic stem cell transplantation, a matched control study. Biol.Blood Marrow Transplant. 8 (9):512-520. [IF = 2,919]
  5. Junghanss, C.. & Marr,K.A. (2002) Infectious risks and outcomes after stem cell transplantation: are non-myeloablative transplants changing the picture? Curr.Opin.Infect.Dis. 15 (4):347-353. [IF = 1,000]
  1. Böhme, A., Ruhnke, M., Karthaus, M., Einsele, H., Guth, S., Heussel, G., Heussel, C.P., Junghanss, C., Kern, W.V., Kubin, T., Sezer, O., Silling, G., Sudhoff, T., Szelenyi, H., Ullmann, A.J. (2001) Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO). Dtsch.Med.Wochenschr., 126, 1440-1447. [IF = 0,704]
  2. Buchheidt, D., Böhme, A., Cornely, O., Fätkenheuer, G., Fuhr, H.G., Heussel, G., Junghanss, C., Karthaus, M., Kellner, O., Kern, W.V., Schiel, X., Sezer, O., Sudhoff, T., & Szelenyi, H. (2001) Documented infections with neutropenia: therapeutic and diagnostic recommendations. Dtsch.Med.Wochenschr., 126, 1085-1090. [IF = 0,704]
  3. Fätkenheuer, G., Buchheidt, D., Fuhr, H.G., Heussel, G., Junghanss, C., Karthaus, M., Kellner, O., Kern, W.V., Kisro, J., Sezer, O., Sudhoff, T.,  Szelenyi, H. (2001) Venous catheter-associated infections in patients with neutropenia. Dtsch.Med.Wochenschr., 126, 89-95. [IF = 0,704]
  4. Junghanss, C, Zaucha, J.M., Yu, C., Zellmer, E., Takatu, A., Little, M.T., Storb, R. (2001) Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyelo-ablative canine transplantation model. Biol.Blood Marrow Transplant., 7, 513-516. [IF = 2,919]
  5. Junghanss, C., Leithäuser, M., Wilhelm, S., Kleine, H.D., Knopp, A., Decker, S., Alscher, A., Casper, J., Köhne, C.H., Freund, M. (2001) High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize. Ann.Hematol., 80, 96-102. [IF = 1,566]
  1. Hinrichs, H., Petershofen, E., Scheinichen, D., Junghanss, C., Kleine, H.D., Poliwoda, H., Freund, M. (1994) Cytokines in chronic lymphocytic leukemia: effects of tumor-necrosis-factor alpha, interferon alpha2b, and stemcell factor in vitro. Proceedings cytokines III, 355-360. [Impact Faktor (IF) = nicht gelistet]
  2. Junghanss, C., Hinrichs, H., Petershofen, E., Kleine, H.D., Poliwoda, H.,  Freund, M. (1994)  Effects of interleukin-2, interleukin-4 and their combination on B chronic lymphocytic leukemia cells in vitro. Proceedings cytokines III, 349-354. [IF = nicht gelistet]

  3. Junghanss, C., Petershofen, E., Wilhelm, S., Decker, S., Lakner, V.,  Freund, M. (1999) An invasive aspergillosis of the larynx in a patient with acute myeloid leukemia. Tumordiag.Ther., 20, 45-48.

  4. Wilhelm, S., Junghanss, C., Leithäuser, M., Krammer-Steiner, B., Heussner, P., Casper, J., Freund, M. (1999) Behandlungsmöglichkeiten der chronisch myeloischen Leukämie in der chronischen Phase. Ärzteblatt Mecklenburg-Vorpommern, 9, 11-17. [IF = nicht gelistet]